BACKGROUND: Platelet rich plasma has been promoted as a biologic agent to enhance tissue healing. As a concentration of autologous growth factors, it has gained increased use in musculoskeletal applications. METHODS: The purpose of this study was to evaluate the effect of intra-operative PRP on patient-reported outcomes 2 years after ACL reconstruction with tibialis anterior allograft. Fifty patients who underwent allograft ACL reconstruction with intra-operative application of PRP to the graft were matched with 50 allograft ACL -reconstructions without PRP use. The same surgeon performed all procedures with identical technique. Two year patient-reported outcomes including KOOS, IKDC, and Marx activity scores were obtained. Effusions in the immediate post-operative period, post-operative complications, and any subsequent procedures were also recorded. RESULTS: There was no difference between the groups with respect to additional surgeries or complications in the first 2 years after reconstruction. Decreased effusions at 10±4 days were noted in the PRP group, but this difference disappeared by 8±4 weeks. No differences in patient-reported outcomes were noted in the 58 patients with two-year outcome data. CONCLUSION: The study demonstrated that although PRP application in tibialis allograft ACL reconstructions appeared safe; clinical benefit was minor and short-term. No differences in patient-reported outcomes or number of additional surgeries at 2 years were noted. LEVEL OF EVIDENCE: Level III - retrospective comparative study.
BACKGROUND: Platelet rich plasma has been promoted as a biologic agent to enhance tissue healing. As a concentration of autologous growth factors, it has gained increased use in musculoskeletal applications. METHODS: The purpose of this study was to evaluate the effect of intra-operative PRP on patient-reported outcomes 2 years after ACL reconstruction with tibialis anterior allograft. Fifty patients who underwent allograft ACL reconstruction with intra-operative application of PRP to the graft were matched with 50 allograft ACL -reconstructions without PRP use. The same surgeon performed all procedures with identical technique. Two year patient-reported outcomes including KOOS, IKDC, and Marx activity scores were obtained. Effusions in the immediate post-operative period, post-operative complications, and any subsequent procedures were also recorded. RESULTS: There was no difference between the groups with respect to additional surgeries or complications in the first 2 years after reconstruction. Decreased effusions at 10±4 days were noted in the PRP group, but this difference disappeared by 8±4 weeks. No differences in patient-reported outcomes were noted in the 58 patients with two-year outcome data. CONCLUSION: The study demonstrated that although PRP application in tibialis allograft ACL reconstructions appeared safe; clinical benefit was minor and short-term. No differences in patient-reported outcomes or number of additional surgeries at 2 years were noted. LEVEL OF EVIDENCE: Level III - retrospective comparative study.
Authors: Eduardo Anitua; Isabel Andía; Mikel Sanchez; Juan Azofra; M del Mar Zalduendo; María de la Fuente; Paquita Nurden; Alan T Nurden Journal: J Orthop Res Date: 2005-03 Impact factor: 3.494
Authors: Martha M Murray; Kurt P Spindler; Eduardo Abreu; John A Muller; Arthur Nedder; Mark Kelly; John Frino; David Zurakowski; Maria Valenza; Brian D Snyder; Susan A Connolly Journal: J Orthop Res Date: 2007-01 Impact factor: 3.494
Authors: Peter A M Everts; Roger J J Devilee; Cornelis J M Oosterbos; Christine Brown Mahoney; Maarten Eeftinck Schattenkerk; Johannes T A Knape; André van Zundert Journal: Knee Surg Sports Traumatol Arthrosc Date: 2007-02-24 Impact factor: 4.342
Authors: Carlos Eduardo da Silveira Franciozi; Sheila Jean McNeill Ingham; Guilherme Conforto Gracitelli; Marcus Vinicius Malheiros Luzo; Freddie H Fu; Rene Jorge Abdalla Journal: Curr Rev Musculoskelet Med Date: 2014-09
Authors: Kyle N Kunze; Jeevana J Pakanati; Amar S Vadhera; Evan M Polce; Brady T Williams; Kevin C Parvaresh; Jorge Chahla Journal: Orthop J Sports Med Date: 2022-02-09
Authors: Berardo Di Matteo; Markus Loibl; Luca Andriolo; Giuseppe Filardo; Johannes Zellner; Matthias Koch; Peter Angele Journal: World J Orthop Date: 2016-09-18